Latest News and Press Releases

WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration...

WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced the presentation of four abstracts that...

Sobi will present three abstracts that highlights data from its myelofibrosis treatment option at ASCO.

FDA has granted Fast Track designation to emapalumab-lzsg for the potential first therapeutic option in patients with MAS

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

WALTHAM, Mass., April 04, 2023 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®) (STO:SOBI), today announced that the Annals of Rheumatic...